Julie O'Connell

Julie O'Connell has a strong background in clinical and scientific affairs, with experience spanning over several companies. Their most recent role is as the Vice President of Clinical and Scientific Affairs at Artelon since March 2021. Prior to this, they served as the Senior Director of Clinical and Scientific Affairs at Lipogems US from December 2018 to March 2021. Julie also held the position of Senior Director of Biologics at Spinal Elements from April 2017 to December 2018.

Julie's earlier work experience includes serving as the Senior Director of Research Development at Amniox Medical from July 2011 to April 2017. In this role, they were responsible for the pre-clinical product development and clinical study execution for regenerative tissue technologies in the Orthopedic and Wound care markets.

Before joining Amniox Medical, they worked as a Senior Scientist II at Zimmer Biomet from October 2004 to July 2011. Here, they led the development and commercialization of novel materials for musculoskeletal repair and served as the primary scientific liaison for product support and sales force training.

Overall, Julie brings extensive expertise in clinical and scientific affairs, along with a strong track record in pre-clinical product development, clinical study execution, and commercialization of regenerative tissue technologies.

Julie O'Connell pursued their education at the University of Washington. From 1990 to 1994, they obtained a Bachelor of Science (B.S.) degree in Microbiology and Immunology. Following this, from 1999 to 2004, Julie earned a Doctor of Philosophy (PhD) degree in Pathology from the same institution.